2021 annual financial data
Akari Therapeutics 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -17,214,136 USD and net income was -17,424,237 USD.
Operating cash flow was -18,846,528 USD.
Get free Akari Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -17,214,136 USD
- Net income
- -17,424,237 USD
- Operating cash flow
- -18,846,528 USD